NCT03990376View on ClinicalTrials.gov

Adolescent Idiopathic Scoliosis (AIS) Gold Standard for Blood Loss

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 19, 2019

Primary Completion Date

September 10, 2020

Study Completion Date

September 10, 2020

Conditions
Adolescent Idiopathic Scoliosis
Interventions
OTHER

Radioisotope I-131-labeled albumin

1 mL of radioisotope I-131-labeled albumin x 2

Trial Locations (1)

30322

Children's Healthcare of Atlanta - Egleston Hospital, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT03990376 - Adolescent Idiopathic Scoliosis (AIS) Gold Standard for Blood Loss | Biotech Hunter | Biotech Hunter